Michael K. Handley

Board Member

Valion Bio, Inc. (VBIO)

COO

Valion Bio, Inc. (VBIO)

CEO

Valion Bio, Inc. (VBIO)

Valion Bio, Inc. (VBIO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Valion Bio, Inc. (VBIO)
CEO

SEC 8-K

Current
2026-03-03–present
Valion Bio, Inc. (VBIO)
SEC 8-K

Current
2025-02-24–present
Valion Bio, Inc. (VBIO)
Board Member

Proxy statement

Current
Valion Bio, Inc. (VBIO)
COO

Proxy statement

Current
Valion Bio, Inc. (VBIO)
CEO

Proxy statement

Start not stated–2026-08-16

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Valion Bio, Inc.

VBIO

Current role

Board Member, COO, CEO

2025-02-24–present

1 call Latest call 2026-05-14

View earnings calls

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Valion Bio, Inc. (VBIO)	CEO	$261,250	—	$305,655	$135,450	—	$23,789	$590,694
2024	Valion Bio, Inc. (VBIO)	CEO	—	—	—	—	—	—	—

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Executive change Terminated: Chief Executive Officer Valion Bio, Inc. (VBIO)
2026-08-16
Earnings call Valion Bio, Inc. Q1 FY2026 Earnings Call Valion Bio, Inc. (VBIO)
2026-05-14
Executive change Appointed: Chief Executive Officer Valion Bio, Inc. (VBIO)
2026-03-03
Executive change Appointed: member of the board of directors Valion Bio, Inc. (VBIO)
2026-03-03
Executive change Appointed: Chief Operating Officer of Tivic Health Valion Bio, Inc. (VBIO)
2025-02-24
Executive change Appointed: President of Tivic Biopharma Valion Bio, Inc. (VBIO)
2025-02-24